sb 203580 has been researched along with peroxynitric acid in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (peroxynitric acid) | Trials (peroxynitric acid) | Recent Studies (post-2010) (peroxynitric acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 1,373 | 8 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kitajima, I; Maruyama, I; Nakajima, T; Nakata, M; Sarker, KP | 1 |
| Créminon, C; Eligini, S; Habib, A; Lebret, M; Lévy-Toledano, S; Maclouf, J | 1 |
2 other study(ies) available for sb 203580 and peroxynitric acid
| Article | Year |
|---|---|
Inhibition of caspase-3 activation by SB 203580, p38 mitogen-activated protein kinase inhibitor in nitric oxide-induced apoptosis of PC-12 cells.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Cell Survival; Enzyme Inhibitors; Imidazoles; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Nitrates; Nitric Oxide; Nitric Oxide Donors; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Pyridines; Rats | 2000 |
Induction of cyclo-oxygenase-2 in human endothelial cells by SIN-1 in the absence of prostaglandin production.
Topics: Blotting, Northern; Blotting, Western; Cell Line; Cyclooxygenase 2; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation, Enzymologic; Humans; Imidazoles; Interleukin-1; Isoenzymes; Membrane Proteins; Mitogen-Activated Protein Kinases; Molsidomine; Nitrates; Precipitin Tests; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyridines; RNA, Messenger; Time Factors; Tumor Necrosis Factor-alpha | 2001 |